Skip to content
HowShorted

Nuvation Bio Inc. short interest in 2022

In 2022, Nuvation Bio Inc.'s disclosed short interest ran from 4.64% of shares outstanding on 14 Jan 2022 to 0.92% on 30 Dec 2022, a change of -3.72 percentage points. The year's high was 7.86% on 15 Jun 2022 and its low 0.92% on 30 Dec 2022, averaging 4.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.77 days on 13 May 2022. Full history: Nuvation Bio Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Nuvation Bio Inc. in 2022

2022 in figures

Start of year
4.64% (14 Jan 2022)
End of year
0.92% (30 Dec 2022)
Change
-3.72 pp
High
7.86% (15 Jun 2022)
Low
0.92% (30 Dec 2022)
Average
4.94%
Highest days to cover
26.77 (13 May 2022)
SEC filings marked
10

Every report in 2022

Nuvation Bio Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20224.64%14.88results (8-K)
31 Jan 20224.93%11.52
15 Feb 20226.46%15.89
28 Feb 20227.16%15.9310-K filed, results (8-K)
15 Mar 20226.73%13.89
31 Mar 20227.59%18.99
14 Apr 20227.77%17.89
29 Apr 20227.52%15.90
13 May 20227.81%26.7710-Q filed, results (8-K)
31 May 20227.82%23.59
15 Jun 20227.86%19.69
30 Jun 20226.96%8.47
15 Jul 20224.37%10.69
29 Jul 20224.28%9.51
15 Aug 20224.13%4.83results (8-K), 10-Q filed, results (8-K)
31 Aug 20223.89%20.54
15 Sep 20223.58%13.26
30 Sep 20222.83%8.40
14 Oct 20222.30%10.56
31 Oct 20222.26%13.64
15 Nov 20222.22%4.2810-Q filed, results (8-K)
30 Nov 20222.25%10.82
15 Dec 20222.17%5.15
30 Dec 20220.92%1.73

See also: Nuvation Bio Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.